1. Home
  2. SDOT vs INBS Comparison

SDOT vs INBS Comparison

Compare SDOT & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sadot Group Inc.

SDOT

Sadot Group Inc.

HOLD

Current Price

$2.82

Market Cap

4.9M

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$5.50

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDOT
INBS
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
SDOT
INBS
Price
$2.82
$5.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
389.1K
425.5K
Earning Date
03-10-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,078,000.00
$3,292,042.00
Revenue This Year
$12.76
$778.48
Revenue Next Year
$5.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.26
52 Week Low
$1.17
$4.03
52 Week High
$35.60
$27.50

Technical Indicators

Market Signals
Indicator
SDOT
INBS
Relative Strength Index (RSI) 47.71 35.42
Support Level $2.68 $8.03
Resistance Level $3.01 $7.40
Average True Range (ATR) 0.25 0.83
MACD -0.06 -0.77
Stochastic Oscillator 16.96 2.31

Price Performance

Historical Comparison
SDOT
INBS

About SDOT Sadot Group Inc.

Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: